Evidence map›Paper›PMID 35402393›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Optimization and Validation of a Custom-Designed Perfusion Bioreactor for Bone Tissue Engineering: Flow Assessment and Optimal Culture Environmental Conditions.

Shuntaro Yamada, Mohammed A Yassin, Thomas Schwarz, Kamal Mustafa, Jan Hansmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Frontiers in bioengineering and biotechnology · 2023
    Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Shuntaro YamadaCentre of Translational Oral Research, Tissue Engineering Group, Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
Mohammed A YassinCentre of Translational Oral Research, Tissue Engineering Group, Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
Thomas SchwarzTranslational Centre Regenerative Therapies, Fraunhofer Institute for Silicate Research ISC, Würzburg, Germany.
Kamal MustafaCentre of Translational Oral Research, Tissue Engineering Group, Department of Clinical Dentistry, University of Bergen, Bergen, Norway.
Jan HansmannTranslational Centre Regenerative Therapies, Fraunhofer Institute for Silicate Research ISC, Würzburg, Germany.
University of Bergen · NOFraunhofer Institute for Silicate Research · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Various perfusion bioreactor systems have been designed to improve cell culture with three-dimensional porous scaffolds, and there is some evidence that fluid force improves the osteogenic commitment of the progenitors. However, because of the unique design concept and operational configuration of each study, the experimental setups of perfusion bioreactor systems are not always compatible with other systems. To reconcile results from different systems, the thorough optimization and validation of experimental configuration are required in each system. In this study, optimal experimental conditions for a perfusion bioreactor were explored in three steps. First, an

Indexed as

bioreactorbone tissue engineeringdynamic cell culturemesenchymal stem cellperfusionregenerative medicineshear stress

Identifiers

PMID35402393
PMCPMC8990132
OpenAlexW4221028408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.